What is the role for bisphosphonates in IBD?
University of Manitoba IBD Clinical and Research Centre, Winnipeg, Manitoba, Canada Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Charles N
CN
Bernstein
University of Manitoba IBD Clinical and Research Centre, Winnipeg, Manitoba, Canada Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Laura E
LE
Targownik
University of Manitoba IBD Clinical and Research Centre, Winnipeg, Manitoba, Canada Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada Department of Radiology, University of Manitoba, Winnipeg, Manitoba, Canada.
William D
WD
Leslie
D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001851:Bone Diseases, Metabolic / Q000188:drug therapy*; D002118:Calcium / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications*; D019587:Dietary Supplements; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D000068296:Risedronic Acid; D014807:Vitamin D / Q000627:therapeutic use*
D050071:Bone Density Conservation Agents; D014807:Vitamin D; D000068296:Risedronic Acid; D012968:Etidronic Acid; D002118:Calcium
BONE DISEASE; BONE MINERAL DENSITY; CROHN'S DISEASE